| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |